Japan’s latest health and drug spending figures illustrate the dilemma of balancing drug pricing policy with the medical needs of a rapidly aging population.
Japan’s latest health and drug spending figures illustrate the dilemma of balancing drug pricing policy with the medical needs of a rapidly aging population.